Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Placebo Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00556959
What this trial is testing

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Addrenex Pharmaceuticals, Inc. 236
Not applicableUnknownNCT03939273
What this trial is testing

The Effects of Gut Micribiota Disruption on the Immune Response After Open Heart Surgery

Who this might be right for
Systemic Inflammatory Response SyndromePostoperative ShockCoronary Artery Disease+1 more
Radboud University Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT01906489
What this trial is testing

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Who this might be right for
AnemiaChronic Kidney Disease
Akebia Therapeutics 210
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Not applicableEnded earlyNCT02335723
What this trial is testing

ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber

Who this might be right for
Septic Shock
Alteco Medical AB 15
Testing effectiveness (Phase 2)Study completedNCT00169559
What this trial is testing

Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Who this might be right for
Dyslipidaemias
GlaxoSmithKline 250
Not applicableNot Yet RecruitingNCT07742150
What this trial is testing

Placebo Effect in Field-Based Physical Performance

Who this might be right for
Physical PerformancePlacebo EffectCognitive Performance
Poznan University of Physical Education 120
Very early researchStudy completedNCT06981260
What this trial is testing

The Role of Sound in Enhancing or Disabling the Placebo Effect of a Deactivated Transcutaneous Electrical Nerve Stimulator (TENS) Device on Hypoalgesia in Healthy Volunteers

Who this might be right for
Healthy
Institute of Health and Resilience 38
Large-scale testing (Phase 3)Study completedNCT05391789
What this trial is testing

Clinical Efficacy of Ulinastatin for Treatment of Sepsis With Systemic Inflammatory Response Syndrome

Who this might be right for
Sepsis
Huashan Hospital 120
Not applicableLooking for participantsNCT07319117
What this trial is testing

Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure.

Who this might be right for
Cognitive AssessmentWorking MemoryExecutive Function (Cognition)+14 more
Leeds Beckett University 40
Large-scale testing (Phase 3)Ended earlyNCT01209689
What this trial is testing

Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy

Who this might be right for
Spondylitis, Ankylosing
Hoffmann-La Roche 113
Not applicableStudy completedNCT04719663
What this trial is testing

The Modulatory Role of Communicated Treatment Rationale on Treatment Expectation Effects in Depression.

Who this might be right for
Condition: Major Depressive Disorder (MDD)
Philipps University Marburg 150
Early research (Phase 1)Ended earlyNCT04762511
What this trial is testing

A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years

Who this might be right for
Herpes Simplex
GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT04718844
What this trial is testing

A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome

Who this might be right for
Non-transfusion-dependent ThalassemiaLow Risk Myelodysplastic SyndromeVery-Low Risk Myelodysplastic Syndrome
Silence Therapeutics plc 44
Early research (Phase 1)Study completedNCT04241965
What this trial is testing

A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

Who this might be right for
Epilepsy
Otsuka Pharmaceutical Development & Commercialization, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT00810836
What this trial is testing

Efficacy and Safety Study of BG00012 With Methotrexate in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 153
Early research (Phase 1)Study completedNCT00574600
What this trial is testing

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06407934
What this trial is testing

Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 1,541
Testing effectiveness (Phase 2)Study completedNCT06676709
What this trial is testing

Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
Universidad Autonoma de Nuevo Leon 80
Testing effectiveness (Phase 2)Ended earlyNCT03821038
What this trial is testing

Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients

Who this might be right for
Sepsis, Severe
Revimmune 21
Next Page